Everest Medicines Commences Operations at its mRNA Vaccine Manufacturing Facility, Accelerating Evolution to a Fully-Integrated Biopharma
--Everest owns complete pharmaceutical and vaccine value chain from discovery, clinical development, manufacturing and commercialization-- --Localizes company's mRNA vaccine production, and helps meet urgent China and global demand for innovative vaccines and medicines-- SHANGHAI, Dec. 28, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines,...
CGTN: Vitality under COVID-19: China gears up for medical supplies
BEIJING, Dec. 28, 2022 /PRNewswire/ -- China has made efforts to ensure the medical supplies needed for COVID-19 prevention and control after it loosened its epidemic measures in early December, which was followed by an increase in infections and surging demand for medicines. The country's National Medical Products Administration has urged medical regulatory authorities at all levels to adopt various enhanced measures, such...
The Top 3 Best Places to Work in Indonesia for 2022 revealed
JAKARTA, Indonesia, Dec. 27, 2022 /PRNewswire/ -- Novo Nordisk, AstraZeneca and Jardine Schindler Indonesia are recognized as the top 3 best places to work in Indonesia for 2022 according to the annual prestigious "Best Places to Work" certification program. Best Places to Work is an international certification program, considered as the 'Platinum Standard' in identifying and recognizing top workplaces around...
Waterdrop Listed among Beijing’s Top 100 Enterprises in Digital Economy
BEIJING, Dec. 27, 2022 /PRNewswire/ -- Recently, Beijing Enterprise Confederation and Beijing Entrepreneurs Association released the Top 100 Enterprises in Beijing list (the List) and the Report on the Development of the Top 100 Enterprises in Beijing (the Report) at the Beijing International Convention Center. Waterdrop Inc.(NYSE: WDH), a company committed to improving the digitization level of the...
Promising Singaporean Medtech Firm Osteopore Achieves Record Revenue, Enters New Markets and Operates in All Major Continents in 2022
SINGAPORE, Dec. 27, 2022 /PRNewswire/ -- Singapore-based Medtech Firm Osteopore announces their record revenue of $460,684 for Q3 CY22, an increase of 6.6% over the preceding quarter. As an extension of the same financial year, Osteopore has likewise broadened their regional operations to span Colombia, South Africa, Spain, and UAE to serve more demographics across the globe. Osteopore was...
Brii Biosciences Provides Update on Strategic Clinical Development Progress
Topline Phase 2 data from multiple hepatitis B viral (HBV) infection functional cure combination studies expected in the first half of 2023 Initiation of Phase 2 postpartum depression (PPD) study planned for early 2023 to advance potential first-of-its-kind treatment U.S. FDA lifted clinical hold on BRII-732 allowing the Company to reinitiate a...
China to downgrade COVID-19 management to Class B
BEIJING, Dec. 27, 2022 /PRNewswire/ -- A report from People's Daily: China will downgrade management of COVID-19 to Class B and cancel quarantine requirements on inbound travelers from Jan. 8, 2023, China's top health authority announced recently. In a statement released late Monday, the National Health Commission (NHC) renamed the Chinese term for COVID-19 from "novel coronavirus pneumonia" to "novel...
EOFlow Submits Application to the U.S. FDA for its Wearable Insulin Pump ‘EOPatch’
Plans to finalize its U.S. distribution strategy in 2023 Aims to enter the U.S., the world's largest diabetes market, with its current disposable wearable insulin pump 'EOPatch' SAN JOSE, Calif. , Dec. 27, 2022 /PRNewswire/ -- EOFlow Co., Ltd. (KOSDAQ: 294090) (EOFlow or the Company), a provider of wearable drug delivery systems (DDS), announced today that it submitted...
Hetero’s ‘Nirmacom’ is world’s first generic version of COVID-19 oral drug ‘PAXLOVID’ to receive WHO Prequalification
Hetero's 'Nirmacom' (Nirmatrelvir), a generic version of Pfizer's COVID-19 oral antiviral drug 'PAXLOVID' is co-packaged with ritonavir tablets With the launch of Nirmacom, Hetero aims to expand access of the ground-breaking antiviral in 95 LMICs including India HYDERABAD, India, Dec. 27, 2022 /PRNewswire/ -- Hetero, India's leading pharmaceutical company with...
Ablaze Pharmaceuticals and Yonghe Pharma Initiate Development and Manufacturing Services Agreement for Targeted Radiopharmaceutical Therapies
SHANGHAI, Dec. 27, 2022 /PRNewswire/ -- Ablaze Pharmaceuticals ("Ablaze") announced the initiation of a development and manufacturing services agreement with Yonghe Pharmaceutical Technology Co., Ltd. ("Yonghe") to develop series of targeted radiopharmaceutical therapy ("TRT") products. Under the agreement. Yonghe as the CDMO partner will provide production process development and cGMP manufacturing services for Ablaze from pharmaceutical research and preclinical...
